Tilray Inc (NASDAQ:TLRY – Get Free Report) saw unusually large options trading activity on Tuesday. Traders bought 67,046 call options on the stock. This is an increase of 88% compared to the average daily volume of 35,633 call options.
Analyst Ratings Changes
Separately, Roth Mkm cut their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a report on Friday, October 11th.
Get Our Latest Stock Report on TLRY
Tilray Stock Up 8.2 %
Tilray (NASDAQ:TLRY – Get Free Report) last released its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting analysts’ consensus estimates of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The company had revenue of $200.00 million for the quarter, compared to analyst estimates of $218.70 million. During the same quarter last year, the firm posted ($0.10) earnings per share. The company’s quarterly revenue was up 13.0% compared to the same quarter last year. As a group, research analysts predict that Tilray will post -0.14 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the company. HighPoint Advisor Group LLC bought a new position in Tilray in the 4th quarter worth approximately $43,000. Madrona Financial Services LLC bought a new stake in shares of Tilray during the first quarter worth $124,000. SpiderRock Advisors LLC bought a new position in shares of Tilray in the first quarter valued at about $247,000. Private Advisor Group LLC raised its holdings in shares of Tilray by 7.3% in the first quarter. Private Advisor Group LLC now owns 175,845 shares of the company’s stock valued at $434,000 after buying an additional 12,021 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Tilray by 8.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock worth $6,699,000 after purchasing an additional 213,834 shares in the last quarter. Institutional investors own 9.35% of the company’s stock.
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Recommended Stories
- Five stocks we like better than Tilray
- What Investors Need to Know About Upcoming IPOs
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Election Stocks: How Elections Affect the Stock Market
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Differences Between Momentum Investing and Long Term Investing
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.